Document is current

Article History

Received: 3 September 2023

Accepted: 26 June 2025

First Online: 5 July 2025

Declarations

:

: This study was approved by the Ethics Review Committee of Chengdu Second People’s Hospital (approval document number 2022055) and was registered with the Chinese Clinical Trial Registry (registration number ChiCTR2200058573). The research protocol adheres to the guidelines set forth in the Declaration of Helsinki. Before participation in the study, participants were informed about the potential benefits of the research as well as the possible adverse events that could occur. Written informed consent (version number 20220225-01) was obtained from each patient before the initiation of the study.

: All authors gave their informed consent to the publication of the article. All patients gave informed consent to the study.

: This study is free from conflicts of interest for the investigator, ethics committee members, guardians of the subjects, or in connection with the publication of the findings.

: The authors have no competing interets to declare that are relevant to the content of this article.